News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Russell Alan J
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $7.08, valued at
$1.4M
|
|
| 05/03/2023 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 1,602 shares
@ $8.9049, valued at
$14.3k
Exercised 5,208 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 220,000 options to buy
@ $10.39, valued at
$2.3M
|
|
| 05/03/2022 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 15,625 restricted stock units
@ $0 |
|
| 12/01/2021 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Exercised 147,585 options to buy
@ $0.18, valued at
$26.6k
Exercised 25,000 options to buy
@ $0.45, valued at
$11.3k
|
|
| 11/17/2021 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 441 shares
@ $19.0708, valued at
$8.4k
Sold 38 shares
@ $19.61, valued at
$745.2 |
|
| 11/12/2021 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 16,864 shares
@ $19.9404, valued at
$336.3k
Sold 12,712 shares
@ $20.2982, valued at
$258k
Sold 11,746 shares
@ $19.7043, valued at
$231.4k
Sold 580 shares
@ $20.2122, valued at
$11.7k
Sold 15,595 shares
@ $19.8168, valued at
$309k
Sold 3,681 shares
@ $20.428, valued at
$75.2k
Sold 8,562 shares
@ $19.5134, valued at
$167.1k
|
|
| 11/08/2021 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 7,392 shares
@ $19.7635, valued at
$146.1k
Sold 6 shares
@ $20.7, valued at
$124.2
Sold 13,036 shares
@ $19.6213, valued at
$255.8k
Sold 9,017 shares
@ $20.1646, valued at
$181.8k
|
|
| 11/03/2021 |
4
| Russell Alan J (Chief Scientific Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 469 shares
@ $18.0246, valued at
$8.5k
Sold 17,519 shares
@ $17.4302, valued at
$305.4k
Sold 20,822 shares
@ $17.9822, valued at
$374.4k
Sold 4,243 shares
@ $18.8415, valued at
$79.9k
Sold 1,119 shares
@ $19.4154, valued at
$21.7k
|
|
| 10/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|